Sigala 100 Dynamic Development Laboratories

£36.00

Sigala 100 Dynamic Development Laboratories is a sildenafil citrate compound investigated in post-cycle therapy research protocols for vascular function studies and endothelial cell analysis in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Sigala 100 Dynamic Development Laboratories
Sigala 100 Dynamic Development Laboratories
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Sigala 100 Research Overview

Sigala 100 Dynamic Development Laboratories is a sildenafil citrate research compound developed for in-vitro laboratory investigations. This pharmaceutical-grade material enables researchers to study phosphodiesterase type 5 (PDE5) inhibition mechanisms and their effects on vascular smooth muscle cells. Research teams utilising this compound can investigate nitric oxide signalling pathways and examine endothelial function responses in controlled experimental conditions. Laboratory studies have focused on this compound’s interaction with cyclic guanosine monophosphate (cGMP) pathways, making it valuable for cardiovascular research applications. Scientists examining post-cycle therapy protocols often investigate how Stroid UK Shop like sildenafil citrate influence vascular recovery mechanisms.

Laboratory Research Applications

Research applications for Sigala 100 span multiple areas of scientific investigation. Cardiovascular researchers examine its effects on vascular smooth muscle relaxation and blood vessel dilation mechanisms. Cell biology studies investigate how PDE5 inhibition influences intracellular signalling cascades and protein phosphorylation pathways. Post-cycle therapy research protocols evaluate this compound’s potential role in supporting vascular health during hormonal transition periods. Scientists studying post cycle therapy compounds analyse its interaction with other research materials. Comparative studies examine differences between sildenafil citrate and other PDE5 inhibitors in laboratory settings. Research teams investigating endothelial dysfunction utilise this compound to study nitric oxide bioavailability and vascular responsiveness. Additionally, researchers exploring SARMs and peptides may include sildenafil citrate studies to examine potential synergistic effects on vascular function.

Technical Specifications

Sigala 100 Research Specifications
Parameter Specification
Active Compound Sildenafil Citrate
Concentration 100mg per tablet
CAS Number 171599-83-0
Molecular Formula C28H38N6O11S
Molecular Weight 666.7 g/mol
Storage Conditions Room temperature, dry environment
Research Grade Laboratory standard

Research Compliance Statement

Sigala 100 Dynamic Development Laboratories is manufactured exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic applications, or any form of in-vivo use. Researchers must ensure compliance with institutional guidelines and regulatory requirements when conducting studies with this compound. All experimental protocols should be reviewed by appropriate oversight committees before commencing research activities.

Related